Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

Triple-negative breast cancer (TNBC) is a highly aggressive phenotype that is resistant to standard therapy. Thus, the development of alternative therapeutic strategies for TNBC is essential. The purpose of our in vitro study was to evaluate the impact of p53 gene silencing in conjunction with the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Braicu, Cornelia, Pileczki, Valentina, Pop, Laura, Petric, Roxana Cojocneanu, Chira, Sergiu, Pointiere, Eve, Achimas-Cadariu, Patriciu, Berindan-Neagoe, Ioana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388814/
https://www.ncbi.nlm.nih.gov/pubmed/25849487
http://dx.doi.org/10.1371/journal.pone.0120936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388814/
https://www.ncbi.nlm.nih.gov/pubmed/25849487
http://dx.doi.org/10.1371/journal.pone.0120936

Ejemplares similares